Related Experiment Video
Updated: Jun 27, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Prostate cancer - a disease in transformation]
1professor, överläkare, Prostatacancercentrum, Sahlgrenska universitetssjukhuset, Göteborg.
Advances in prostate cancer (prostate-specific antigen) screening and treatment have halved mortality for men under 85. Improved diagnostics reduce overdiagnosis, enhancing patient care and research through national registries.
Area of Science:
- Oncology
- Urology
- Public Health
Background:
- The introduction of prostate-specific antigen (PSA) testing and prostate biopsies in the 1990s led to increased diagnoses of localized prostate cancer and radical treatments.
- Significant advancements in diagnostic methods and a deeper understanding of tumor biology have been crucial in refining prostate cancer care.
Purpose of the Study:
- To provide an overview of contemporary prostate cancer care, highlighting key advancements and their impact.
- To discuss the evolution of diagnostic and treatment strategies in prostate cancer management.
- To emphasize the role of national registries and patient organizations in improving prostate cancer outcomes.
Main Methods:
- Review of contemporary prostate cancer care practices and advancements.
- Analysis of the impact of new diagnostic tools and treatments on patient outcomes.
- Examination of the role and evolution of the National Prostate Cancer Register of Sweden (NPCR).
Main Results:
- The incidence of localized prostate cancer and radical treatment use rose significantly following the introduction of PSA testing and biopsies.
- Improved diagnostics and understanding of tumor biology are now mitigating overdiagnosis and enabling organized screening.
- Age-standardized prostate cancer mortality in men under 85 has been halved due to more effective treatments and earlier diagnosis.
Conclusions:
- Contemporary prostate cancer care has seen dramatic improvements, leading to reduced mortality.
- Organized screening, advanced diagnostics, and effective treatments are key to better patient outcomes.
- National registries like the NPCR are vital for supporting clinical care and research, alongside the growing influence of patient organizations.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Cancer
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell

